Oncogenic upregulation of MACC1 in CRC cells enhances its binding affinity to the ABCB1 promoter region and amplifies transcriptional activation, culminating in increased ABCB1 protein abundance and consequent resistance to first-line therapeutic agents [26]. The gene discussed is ABCB1; the disease is colorectal carcinoma.